Table 1:

Clinical and demographic characteristics of the patients and control subjects*

FE GroupChronic GroupCombined Group
FE Patients (n = 12)Controls (n = 14)Chronic Patients (n = 16)Controls (n = 14)All Patients (n = 28)All Controls (n = 28)
Age (y)25.50 ± 5.7625.16 ± 5.3529.31 ± 11.4128.93 ± 10.2427.65 ± 9.4627.32 ± 8.58
Male/Female8/49/511/59/519/918/10
Education (y)10.33 ± 4.4710.33 ± 3.8911.00 ± 3.6511.00 ± 3.4010.71 ± 3.9610.71 ± 3.56
Age at onset (y)24.83 ± 5.3022.37 ± 8.7223.35 ± 7.13
No. of hospitalizations4.30 ± 3.90
DUP (months)11.20 ± 10.20
Duration of illness (months)83.25 ± 68.65
Psychopathology scores
    BPRS58.75 ± 8.6067.56 ± 11.1863.92 ± 10.96
    SANS40.00 ± 17.6250.37 ± 26.9345.92 ± 23.60
    SAPS36.58 ± 17.1143.87 ± 15.8940.75 ± 16.52
  • Note:—FE indicates first-episode; –, data not available.; DUP, duration of untreated psychosis; BPRS, Brief Psychiatric Rating Scale; SANS, Scale for the Assessment of Negative Symptoms; SAPS, Scale for the Assessment of Positive Symptoms.

  • * Data are given as mean ± SDs except where indicated.